[Phospholine iodide and opacity of the lens].
作者信息
Dake C L, Kerlen C H
出版信息
Ned Tijdschr Geneeskd. 1968 Oct 19;112(42):1898-901.
PMID:5686456
Abstract
摘要
相似文献
1
[Phospholine iodide and opacity of the lens].[碘化磷酰硫胆碱与晶状体混浊]
Ned Tijdschr Geneeskd. 1968 Oct 19;112(42):1898-901.
2
Glaucoma, miotic therapy and cataract. I. The frequency of anterior subcapsular vacuoles in glaucoma eyes treated with echothiophate (Phospholine Iodide), pilocarpine or pilocarpine-eserine, and in nonglaucomatous untreated eyes with common senile cataract.
Acta Ophthalmol (Copenh). 1968;46(1):83-98.
3
[Absence of cataractogenic effect of 0.03 percent phospholine iodide].[0.03%碘化磷酰硫胆碱无致白内障作用]
Bull Soc Ophtalmol Fr. 1971 Sep-Oct;71(9):885-9.
4
Lens opacities in glaucoma patients on phospholine iodide therapy.
Trans Ophthalmol Soc U K (1962). 1966;86:89-100.
5
Glaucoma, miotic therapy and cataract. V. Studies on the lens in glaucoma eyes after discontinuance of echothiophate (phospholine iodide) therapy.
Acta Ophthalmol (Copenh). 1969;47(4):1049-56. doi: 10.1111/j.1755-3768.1969.tb03730.x.
6
Glaucoma, miotic therapy and cataract. 3. Visual loss due to lens changes in glaucoma eyes treated with paraoxon (Mintacol), echothiophate (phospholine iodide) or pilocarpine.青光眼、缩瞳疗法与白内障。3. 使用对氧磷（米塔可）、碘依可酯（碘化磷酰硫胆碱）或毛果芸香碱治疗青光眼时因晶状体变化导致的视力丧失。
Acta Ophthalmol (Copenh). 1968;46(4):831-45. doi: 10.1111/j.1755-3768.1968.tb02883.x.
7
Lens opacities in glaucoma patients on phospholine iodide therapy.接受碘化磷酰硫胆碱治疗的青光眼患者的晶状体混浊
Am J Ophthalmol. 1966 Oct;62(4):619-28. doi: 10.1016/0002-9394(66)92182-9.
8
[Phospholine iodide in the management of glaucoma].[磷酰碘胆碱在青光眼治疗中的应用]
Klin Monbl Augenheilkd. 1971 Mar;158(3):413-7.
9
Uniocular miotic therapy.
Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol. 1975 Mar-Apr;79(2):OP376-80.
10
[Notes on 0.03% phospholine iodide, with more than 4 years' experience].[关于0.03%碘磷灵的笔记，有超过4年的经验]
Bull Soc Ophtalmol Fr. 1976 Mar;76(3):249-50.
Zotero 插件